283 related articles for article (PubMed ID: 32695664)
1. High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions.
Allouch S; Malki A; Allouch A; Gupta I; Vranic S; Al Moustafa AE
Front Oncol; 2020; 10():914. PubMed ID: 32695664
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
[TBL] [Abstract][Full Text] [Related]
3. PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives.
Wang Y; Li G
Front Med; 2019 Aug; 13(4):438-450. PubMed ID: 30826965
[TBL] [Abstract][Full Text] [Related]
4. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
Aghbash PS; Hemmat N; Baradaran B; Mokhtarzadeh A; Poortahmasebi V; Oskuee MA; Baghi HB
Oncol Res; 2022; 30(3):99-116. PubMed ID: 37305016
[TBL] [Abstract][Full Text] [Related]
5. CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts
Chen X; He H; Xiao Y; Hasim A; Yuan J; Ye M; Li X; Hao Y; Guo X
Front Oncol; 2021; 11():629350. PubMed ID: 34422627
[TBL] [Abstract][Full Text] [Related]
6. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
7. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
[TBL] [Abstract][Full Text] [Related]
8. PD-1/PD-L1 Inhibitors in Cervical Cancer.
Liu Y; Wu L; Tong R; Yang F; Yin L; Li M; You L; Xue J; Lu Y
Front Pharmacol; 2019; 10():65. PubMed ID: 30774597
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability in E6, E7 and L1 genes of Human Papillomavirus 62 and its prevalence in Mexico.
Artaza-Irigaray C; Flores-Miramontes MG; Olszewski D; Magaña-Torres MT; López-Cardona MG; Leal-Herrera YA; Piña-Sánchez P; Jave-Suárez LF; Aguilar-Lemarroy A
Infect Agent Cancer; 2017; 12():15. PubMed ID: 28270859
[TBL] [Abstract][Full Text] [Related]
10. Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.
Tomaić V
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27775564
[TBL] [Abstract][Full Text] [Related]
11. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
12. Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells
Gupta I; Jabeen A; Vranic S; Al Moustafa AE; Al-Thawadi H
Front Oncol; 2021; 11():630408. PubMed ID: 33777781
[TBL] [Abstract][Full Text] [Related]
13. Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Liu JH; Lu ZT; Wang GL; Zhou WQ; Liu C; Yang LX; Sun ZR; Ruan Q
Infect Genet Evol; 2012 Oct; 12(7):1466-72. PubMed ID: 22659102
[TBL] [Abstract][Full Text] [Related]
14. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
15. HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
Đukić A; Lulić L; Thomas M; Skelin J; Bennett Saidu NE; Grce M; Banks L; Tomaić V
Pathogens; 2020 Feb; 9(2):. PubMed ID: 32085533
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly.
Boon SS; Chen Z; Li J; Lee KYC; Cai L; Zhong R; Chan PKS
BMC Cancer; 2019 Dec; 19(1):1211. PubMed ID: 31830929
[TBL] [Abstract][Full Text] [Related]
17. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8
Çuburu N; Khan S; Thompson CD; Kim R; Vellinga J; Zahn R; Lowy DR; Scheper G; Schiller JT
Int J Cancer; 2018 Apr; 142(7):1467-1479. PubMed ID: 29159802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
